Prognostic implications of adhesion molecule expression in colorectal cancer.
- 1 April 2015
- journal article
- Vol. 8 (4) , 4148-57
Abstract
Research on the expression of adhesion molecules, E-cadherin (ECAD), CD24, CD44 and osteopontin (OPN) in colorectal cancer (CRC) has been limited, even though CRC is one of the leading causes of cancer-related deaths. This study was conducted to evaluate the expression of adhesion molecules in CRC and to determine their relationships with clinicopathologic variables, and the prognostic significance. The expression of ECAD, CD24, CD44 and OPN was examined in 174 stage II and III CRC specimens by immunohistochemistry of TMA. Negative ECAD expression was significantly correlated with advanced nodal stage and poor tumor differentiation. Multivariate analysis showed that both negative expression of ECAD and positive expression of CD24 were independent prognostic factors for disease-free survival (DFS) in CRC patients (P<0.001, relative risk [RR] = 5.596, 95% CI = 2.712-11.549; P = 0.038, RR = 3.768, 95% CI = 1.077-13.185, respectively). However, for overall survival (OS), only ECAD negativity showed statistically significant results in multivariate analysis (P<0.001, RR = 4.819, 95% CI = 2.515-9.234). Positive expression of CD24 was associated with poor OS in univariate analysis but was of no prognostic value in multivariate analysis. In conclusion, our study suggests that among these four adhesion molecules, ECAD and CD24 expression can be considered independent prognostic factors. The role of CD44 and OPN may need further evaluation.Keywords
This publication has 29 references indexed in Scilit:
- CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancerJournal of Clinical Pathology, 2009
- Expression of standard CD44 in human colorectal carcinoma: Association with prognosisPathology International, 2009
- Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinomaJournal of Surgical Oncology, 2006
- Osteopontin regulates multiple functions contributing to human colon cancer development and progressionClinical & Experimental Metastasis, 2004
- Engagement of CD44 Promotes Rac Activation and CD44 Cleavage during Tumor Cell MigrationJournal of Biological Chemistry, 2004
- Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular FeaturesLaboratory Investigation, 2003
- Osteopontin Identified as Lead Marker of Colon Cancer Progression, Using Pooled Sample Expression ProfilingJNCI: Journal of the National Cancer Institute, 2002
- Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinomaDiseases of the Colon & Rectum, 2000
- Prognostic value of the expression of E-cadherin and β-catenin in bladder cancerEuropean Journal of Cancer, 2000
- E-cadherin mediated adhesion system in cancer cellsCancer, 1996